Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts ...
By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care ...
The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of ...
Some needles were manufactured with incorrect dimensions, making it difficult to remove the stylet after placement.
The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw ...
Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.
The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product ...
The University of Oxford spinout will soon launch the AI tool, which research suggests could help assess heart attack risk in ...
Rocco De Bernardis, global president for Ottava, gets into the details of what makes the new robotic surgery system different ...
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to ...
The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity ...